Pathophysiology of levodopa-induced dyskinesias in Parkinson's disease: Problems with the current model

Annals of Neurology

Volumn 47, Issue 4 SUPPL. 1, 2000, Pages

  Obeso, Jose A ^a,e   Rodriguez Oroz, Maria C ^a   Rodriguez, Manual ^b   DeLong, Mahlon R ^c   Olanow, C Warren ^d  

^a UNIVERSITY OF NAVARRA   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; CYTOCHROME C OXIDASE; DEOXYGLUCOSE; GLUTAMATE DECARBOXYLASE; LEVODOPA;

ANIMAL EXPERIMENT; ANIMAL MODEL; BASAL GANGLION; BODY POSTURE; BRADYKINESIA; BRAIN CORTEX; CONFERENCE PAPER; CONTROLLED STUDY; DRUG INDUCED DISEASE; DYSKINESIA; GAIT DISORDER; GLOBUS PALLIDUS; MODEL; MONKEY; MUSCLE RIGIDITY; NONHUMAN; PARKINSON DISEASE; PRIORITY JOURNAL; SUBSTANTIA NIGRA; SUBTHALAMIC NUCLEUS; TREMOR;

BASAL GANGLIA; BRAIN CHEMISTRY; DOPAMINE AGENTS; DYSKINESIA, DRUG-INDUCED; HUMANS; LEVODOPA; PARKINSON DISEASE;

EID: 0034109592     PISSN: 03645134     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (101)

1. Fahn S. Fluctuations of disability in Parkinson's disease: pathophysiology. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth, 1982:123-145
2. Obeso JA, Grandas F, Vaamonde J, et al. Motor complications associated with chronic levodopa therapy in Parkinson's disease. Neurology 1989;39(suppl 2):11-19
3. Tolosa ES, Martin WE, Cohen HP, Jacobson RL. Patterns of clinical response and plasma levodopa levels in Parkinson's disease. Neurology 1975;25:177-183
4. Lhermitte F, Agid Y, Signoret JL. Onset and end-of-dose levodopa-induced dyskinesias. Arch Neurol 1978;35:261-262
5. Muenter MD, Sharpless NS, Tyce GM, Darley FL. Patterns of dystonia ('I-D-I' and 'D-I-D') in response to levodopa therapy for Parkinson's disease. Mayo Clin Proc 1977;52:163-174
6. Marsden CD, Parkes JD, Quinn NP. Fluctuations of disability in Parkinson's disease: clinical presentations. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth, 1982:84-122
7. Luquin MR, Luquin MR, Scipioni O, et al. Levodopa-induced dyskinesias in Parkinson's disease. Clinical and pharmacological classification. Mov Disord 1992;7:117-124
8. Marsden CD, Parkes JD, Quinn NP. Fluctuations of disability in Parkinson's disease: clinical aspects. In: Marsden CD, Fahn S, eds. Movement disorders. London: Butterworth, 1982:96-122
9. Marsden CD, Obeso JA, Rothwell JC. The clinical neurophysiology of muscle jerks: myoclonus, chorea and tics. In: Desmedt J, ed. Brain and spinal mechanisms of movement control in man. New York: Raven Press, 1983:313-322
10. Albin R, Young A, Penney J. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:336-374
11. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285
12. Crossman AR. Primate models of dyskinesia: the experimental approach to the study of basal ganglia-related involuntary movement disorders. Neuroscience 1987;21:1-40
13. Kunzle H. Projections from the primary somatosensory cortex to basal ganglia and thalamus in the monkey. Exp Brain Res 1977; 30:481-492
14. DeLong MR, Georgopoulos AP. Motor functions of the basal ganglia. In: Brookhart JM, Mountcastle VB, Brooks VB, Geiger SR, eds. Handbook of physiology. The nervous system: motor control. Bethesda, MD: American Physiological Society, 1981: sect 1, vol 2, part 2;1017-1061
15. Gerfen RC, McGinty JF, Young WS. Dopamine differentially regulates dynorphin, substance P and enkephalin in striatal neurons: in situ hybridization histochemical analysis. J Neurosci 1991;11:1016-1031
16. Duty S, Henry B, Crossman AR, Brotchie JM. Topographical organization of opioid peptide precursor gene expression following repeated apomorphine treatment in the 6-hydroxydopamine-lesioned rat. Exp Neurol 1998;150:223-234
17. Obeso JA, Rodriguez MC, DeLong MR. Pathophysiology of the basal ganglia: a critical review. Adv Neurol 1997;74:3-18
18. Filion M, Tremblay L, Bédard P. Abnormal influences of passive limb movement on the activity of globus pallidus neurons in parkinsonian monkeys. Brain Res 1988;444:165-176
19. Miller WC, DeLong MR. Altered tonic activity of neurons in the globus pallidus and subthalamic nucleus in the primate MPTP model of parkinsonism. In: Carpenter MB, Jayaraman A, eds. The basal ganglia II. New York: Plenum Press, 1987:415-427
20. Bergman H, Wichmann T, Karmon B, DeLong MR. The primate subthalamic nucleus. II. Neuronal activity in the MPTP model of parkinsonism. J Neurophysiol 1994;72:507-519
21. Starr PA, Vitek JL, Bakay RAE. Ablative surgery and deep brain stimulation for Parkinson's disease. J Neurosurg 1998;43: 989-1013
22. Rodriguez MC, Guridi J, Gorospe A, et al. Neurophysiological characteristics of the subthalamic nucleus in Parkinson's disease [abstract]. Neurology 1997;48(suppl 1):433
23. Huchinson WD, Allan RJ, Opitz H, et al. Neurophysiological identification of the subthalamic nucleus in surgery for Parkinson's disease. Ann Neurol 1998;44:622-628
24. Bergman H, Wichmann T, DeLong MR. Reversal of experimental parkinsonism by lesions of the subthalamic nucleus. Science 1990;249:1436-1438
25. Aziz TZ, Peggs D, Sambrook MA, Crossman AR. Lesion of subthalamic nucleus for the alleviation of MPTP-induced parkinsonism in the primate. Mov Disord 1991;6:288-293
26. Guridi J, Herrero MT, Luquin MR, et al. Subthalamotomy in parkinsonian monkeys. Behavioural and biochemical analysis. Brain 1996;119:1717-1727
27. Obeso JA, Guridi J, DeLong MR. Surgery for Parkinson's disease. J Neurol Neurosurg Psychiatry 1997;62:2-8
28. Olanow CW. Pallidotomy - have we made a dent in Parkinson's disease? Ann Neurol 1996;40:341-343
29. Baron MS, Vitek JL, Bakay RAE, et al. Treatment of advanced Parkinson's disease by posterior GPi pallidotomy: 1-year results of a pilot study. Ann Neurol 1996;40:355-366
30. Lang AE, Lozano A, Montgomery E, et al. Posteroventral medial pallidotomy in advanced Parkinson's disease. N Engl J Med 1997; 337:1036-1042
31. Limousin P, Krack P, Pollak P, et al. Electrical stimulation of the subthalamic nucleus in Parkinson's disease. N Engl J Med 1998; 339:1105-1111
32. Kumar R, Lozano AM, Kim YJ, et al. Double-blind evaluation of subthalamic nucleus deep brain stimulation in advanced Parkinson's disease. Neurology 1998;51:850-855
33. Eidelberg D, Moeller JR, Ishikawa T, et al. Regional metabolic correlates of surgical outcome following unilateral pallidotomy for Parkinson's disease. Ann Neurol 1996;39:450-459
34. Limousin P, Greene J, Pollak P, et al. Changes in cerebral activity pattern due to subthalamic nucleus or internal pallidum stimulation in Parkinson's disease. Ann Neurol 1997;42:283-291
35. Brown RG, Limousine-Dowsey P, Brown P, et al. Impact of deep brain stimulation on upper limb akinesia in Parkinson's disease. Ann Neurol 1999;45:473-488
36. Limousin P, Brown RG, Jahanshani M, et al. The effects of posteroventral pallidotomy on the preparation and execution of voluntary hand and arm movements in Parkinson's disease. Brain 1999;122:303-314
37. Lang AP, Lozano A. Parkinson's disease. N Engl J Med 1999;339: 1130-1143
38. Levy R, Hazrati LN, Herrero MT, et al. Re-evaluation of the functional anatomy of the basal ganglia in normal and parkinsonian states. Neuroscience 1997;76:335-343
39. Parent A, Cicchetti F. The current model of basal ganglia organization under scrutiny. Mov Disord 1998;13:199-203
40. Cardoso F, Jankovic J, Grossman RG, Hamilton WJ. Outcome after stereotactic thalamotomy for dystonia and hemiballism. Neurosurgery 1995;36:501-507
41. Marsden CD, Obeso JA. The functions of the basal ganglia and the paradox of stereotaxic surgery in Parkinson's disease. Brain 1994;117:877-897
42. Wichmann T, DeLong MR. Functional and pathophysiological models of the basal ganglia. Curr Opin Neurobiol 1996;6: 751-758
43. Mitchell IJ, Jackson A, Sambrook MA, Crossman AR. Common neural mechanisms in experimental chorea and hemiballismus in the macaque monkey: evidence from 2-deoxyglucose studies. Brain Res 1985;339:346-350
44. Crossman AR, Mitchell IJ, Jackson A, Sambrook MA. Chorea and myoclonus in the monkey induced by gamma-aminobutyric acid antagonism in the lentiform complex: the site of drug action and a hypothesis of the neural mechanisms of chorea. Brain 1988;111:1211-1233
45. Crossman AR, Mitchell IJ, Jackson A, Sambrook MA. The role of the subthalamic nucleus in experimental chorea: evidence from 2-deoxyglucose metabolic mapping and horseradish peroxidase tracing studies. Brain 1989;112:1533-1548
46. Hamada I, DeLong MR. Excitotoxic lesions of the primate subthalamic nucleus result in transient dyskinesias of the contralateral limbs. J Neurophysiol 1992;68:1850-1858
47. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 1992;68:1859-1866
48. Matsumura M, Tremblay L, Richard H, Filion M. Activity of pallidal neurons in the monkey duting dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 1995;65:59-70
49. Kato M, Kimura M. Effects of reversible blockade of basal ganglia on a voluntary arm movement. J Neurophysiol 1992;68:1516-1534
50. Burbaud P, Bonnet B, Guehl D, et al. Movement disorders induced by gamma-aminobutyric agonist and antagonist injections into the internal globus pallidus and substantia nigra pars reticulata of the monkey. Brain Res 1998;780:102-107
51. Reiner A, Albin RL, Anderson KD, et al. Differential loss of striatal projection neurons in Huntington's disease. Proc Natl Acad Sci USA 1988;85:5733-5737
52. Filion M, Tremblay L, Bédard PJ. Effects of dopamine agonists on the spontaneous activity of globus pallidus neurons in monkeys with MPTP-induced parkinsonism. Brain Res 1991;547:152-161
53. Merello M, Balej J, Delfino M, et al. Apomorphine induces changes in GPi spontaneous outflow in patients with Parkinson's disease. Mov Disord 1999;14:45-49
54. Hutchison WD, Levy R, Dostrovsky JO, et al. Effects of apomorphine on globus pallidus neurons in Parkinsonian patients. Ann Neurol 1997;42:767-775
55. Lozano AM, Lang AE, Levy R, et al. Neuronal recordings in PD patients with dyskinesias induced by apomorphine. Ann Neurol 2000;47(suppl 1):S141-S146
56. Mitchell IJ, Boyce S, Sambrook MA, Crossman AR. A 2-deoxyglucose study of the effects of dopamine agonists on the parkinsonian primate brain. Implications for the neural mechanisms that mediate dopamine agonist-induced dyskinesia. Brain 1992;115:809-824
57. Crossman AR. A hypothesis on the pathophysiological mechanisms that underlie levodopa or dopamine agonist-induced dyskinesia in Parkinson's disease. Mov Disord 1990;5:100-108
58. Olanow CW, Obeso JA. Preventing levodopa-induced dyskinesias. Ann Neurol 2000;47(suppl 1):S167-S178
59. Gerfen CR, Engber TM, Mahan LC, et al. D1 and D2 dopamine receptor mediated regulation of gene expression in striatonigral and striatopallidal pathways. Science 1990;250:1429-1432
60. Young WS III, Bonner TI, Brann MR. Mesencephalic dopaminergic neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc Natl Acad Sci USA 1986;83:9827-9831
61. Herrero MT, Augood SJ, Hirsch EC, et al. Effects of L-dopa on preproenkephalin and preprotachykinin gene expression in the MPTP-treated monkey striatum. Neuroscience 1995;68:1189-1198
62. Morissette M, Goulet M, Soghomonian JJ, et al. Preproenkephalin mRNA expression in the caudate-putamen of MPTP monkeys after chronic treatment with the D2 agonist U91356A in continuous or intermittent mode of administration: comparison with L-DOPA therapy. Mol Brain Res 1997;49:55-62
63. Jolkkonen J, Jenner P, Marsden CD. L-DOPA reverses altered gene expression of substance P but not enkephalin in the caudate-putamen of common marmosets treated with MPTP. Brain Res Mol Brain Res 1995;32:297-307
64. Morissette M, Grondin R, Goulet M, et al. Differential regulation of striatal preproenkephalin and preprotachykinin mRNA levels in MPTP-lesioned monkeys chronically treated with dopamine D1 or D2 receptor agonists. J Neurochem 1999;72: 682-692
65. Pearce RKB, Zeng BY, Jenner P, Marsden CD. Altered striatal preproenkephalin mRNA levels in normal macaque monkeys (Macaca fascicularis) with dyskinesias induced by chronic L-dopa adminisrration [abstract]. Br J Pharmacol 1995;116:78
66. Piccini P, Weeks RA, Brooks DJ. Alterations in opioid receptor binding in Parkinson's disease patients with levodopa-induced dyskinesia. Ann Neurol 1997;42:720-726
67. 11C]-diprenorphine PET study. Brain 1995;118:951-958
68. Vila M, Feger J, Perier C, et al. Evolution of changes in neuronal activity in the subthalamic nucleus of rats with unilateral lesion of the substantia nigra assessed in parallel by metabolic and electrophysiologic measurements. Eur J Neurosci (in press)
69. Herrero M-T, Levy R, Ruberg M, et al. Consequence of nigrostriatal denervation and L-dopa therapy on the expression of glutamic acid decarboxylase (GAD) messenger RNA in the pallidum. Neurology 1996;47:219-224
70. Vila M, Levy R, Herrero MT, et al. Consequences of nigrostriatal denervation on the functioning of the basal ganglia in human and nonhuman primates: an in situ hybridization study of cytochrome oxidase subunit I mRNA. J Neurosci 1997;17:765-773
71. Blanchet PJ, Boucher R, Bédard PJ. Excitotoxic lateral pallidotomy does not relieve L-dopa-induced dyskinesia in MPTP parkinsonian monkey. Brain Res 1994;650:32-39
72. Carpenter MB, Whittier JR, Mettler FA. Analysis of choreoid hyperkinesia in the rhesus monkey: surgical and pharmacological analysis of hyperkinesia resulting from lesions in the subthalamic nucleus of Luys. J Comp Neurol 1950;92:293-331
73. Suarez JI, Vrehagen Metman L, Reich SG, et al. Pallidotomy for hemiballismus efficacy and characteristics of neuronal activity. Ann Neurol 1997;42:807-810
74. Vidakovic A, Dragasevic N, Kostic VS. Hemiballism: report of 25 cases. J Neurol Neurosurg Psychiatry 1994;58:945-949
75. Guridi J, Obeso JA. The role of the subthalamic nucleus in the origin of hemiballism and parkinsonism: new surgical perspectives. Adv Neurol 1997;74:235-248
76. Olanow CW, Germano IM, Gracies JM, et al. High frequency stimulation of the subthalamic nucleus as a treatment for Parkinson's disease: a prospective 12 month study. Neurosurgery (in press)
77. Rodriguez MC, Guridi J, Alvarez L, et al. The subthalamic nucleus and tremor in Parkinson's disease. Mov Disord 1998; 13(suppl 3):111-118
78. Papa SM, Desimore R, Fioroni M, Oldfield EH. Internal globus pallidus discharge is nearly suppressed during levodopa-induced dyskinesia. Ann Neurol 1999;46:732-738
79. Vitek JL, Chockkan V, Zhang J-Y, et al. Neuronal activity in the basal ganglia in patients with generalized dystonia and hemiballismus. Ann Neurol 1999;46:22-35
80. Matsumura M, Tremblay L, Richard H, Filion M. Activity of pallidal neurons in the monkey during dyskinesia induced by injection of bicuculline in the external pallidum. Neuroscience 1995;65:59-70
81. Marsden CD. The mysterious motor function of the basal ganglia. Neurology 1982;32:514-539
82. Rizzolati G. Functional organization of inferior area 6. Motor areas of the cerebral cortex. Ciba Foundation Symposium 1992; 132:171-187
83. Alexander GE. Selective neuronal discharge in monkey putamen reflects intended direction of planed limb movements. Exp Brain Res 1987;67:623-634
84. Fetz EE. Temporal coding in neural populations? Science 1997; 278:1901-1902
85. Mushiake H, Strick PL. Pallidal neuron activity during sequential arm movements. J Neurophysiol 1995;74:2754-2758
86. Robledo P, Feger J. Excitatory influence of rat subthalamic nucleus to substantia nigra pars reticulata and the pallidal complex: electrophysiological data. Brain Res 1990;518:47-54
87. Benazzouz A, Piallat B, Pollak P, Benabid AL. Responses of substantia nigra pars reticulata and globus pallidus complex to high frequency stimulation of the subthalamic nucleus. Neurosci Lett 1995;189:77-80
88. Hamada I, DeLong MR. Excitotoxic acid lesions of the primate subthalamic nucleus result in reduced pallidal neuronal activity during active holding. J Neurophysiol 1992;68:1859-1866
89. Shink E, Bevan MD, Bolam JP, Smith Y. The subthalamic nucleus and the external pallidum: two tightly interconnected structures that control the output of the basal ganglia in the monkey. Neuroscience 1996;73:335-357
90. Hoover JE, Strick PL. Multiple output channels in the basal ganglia. Science 1993;259:819-821
91. Nambu A, Yoshida S, Jinnai K. Discharge patterns of pallidal neurons with input from various cortical areas during movement in the monkey. Brain Res 1990;519:183-191
92. Nambu A, Takada M, Inase M, Tokuno H. Dual somatotopical representations in the primate subthalamic nucleus: evidence for ordered but reversed body-map transformations from the primary motor cortex and the supplementary motor area. J Neurosci 1996;16:2671-2683
93. Nambu A, Tokuno H, Inase M, Takada M. Corticosubthalamic input zones from forelimb representations of the dorsal and ventral divisions of the premotor cortex in the macaque monkey: comparison with the input zones from the primary motor cortex and the supplementary motor area. Neurosci Lett 1997;239: 13-16
94. Ryan LJ, Clark KB. The role of the subthalamic nucleus in the response of globus pallidus neurons to stimulation of the prelimbic and agranular frontal cortices in rats. Exp Brain Res 1991;86:641-651
95. Papa SM, Chase TN. Levodopa-induced dyskinesias improved by a glutamate antagonist in parkinsonian monkeys. Ann Neurol 1996;39:574-578
96. Brooks DJ, Piccini P, Turjanski N, et al. Understanding dyskinesias via neuroimaging. Mov Disord 1998;13(suppl 2):12-13
97. Brooks DJ, Piccini P, Turjanksi N, Samuel M. Neuroimaging of dyskinesia. Ann Neurol 2000;47(suppl 1):S154-S159
98. Benabid AL, Pollak P, Gao D, et al. Chronic electrical stimulation of the ventralis intermedius nucleus of the thalamus as a treatment of movement disorders. J Neurosurg 1996;84:203-214
99. Floran B, Floran L, Sierra A, Aceves J. D-2 receptor-mediated inhibition of GABA release by endogenous dopamine in the rat globus pallidus. Neurosci Lett 1997;237:1-4
100. Kreiss DS, Anderson LA, Walters JR. Apomorphine and dopamine D-1 receptor agonists increase the firing rate of subthalamic nucleus neurons. Neuroscience 1996;72:863-876
101. Kreiss DS, Mastropietro CW, Rawji S, Walters JR. The response of subthalamic nucleus neurons to dopamine receptor stimulation in a rodent model of Parkinson's disease. J Neurosci 1997;17: 6807-6819